Inoperable oropharyngeal carcinoma treated with concomitant irradiation, mitomycin C and bleomycin - Long term results

Neoplasma

Volumn 52, Issue 2, 2005, Pages 165-174

  Budihna, M ^a   Soba E ^b   Smid L ^a   Zakotnik, B ^a   Strojan, P ^a   Cemazar M ^a   Fajdiga, I ^b   Zargi M ^b   Zupevc A ^b   Lesnicar H ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b Univ Dept of Otorhinolaryngology   (Slovenia)

Author keywords

Bleomycin; Dose response; Mitomycin; Oropharyngeal carcinoma; Radiochemotherapy

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANEMIA; ARTICLE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTAL CARIES; DERMATITIS; DOSE RESPONSE; DRUG FATALITY; EDEMA; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; INOPERABLE CANCER; LEUKOPENIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NECROSIS; NERVE PARALYSIS; NEUTROPENIA; OROPHARYNX CARCINOMA; PNEUMONIA; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; SQUAMOUS CELL CARCINOMA; TELANGIECTASIA; THROMBOCYTOPENIA; TRISMUS; WEIGHT REDUCTION; XEROSTOMIA;

EID: 20144387315     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. ADELSTEIN DJ, SAXTON JP, LAVERTU P, TUASON L, WOOD BG et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone with resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 1997; 19: 567-575.
2. ARMITAGE P. Statistical methods in medical research. Oxford: Blackwell Scientific, 1971.
3. AUERSPERG M, ŠOBA E, VRASPIR-PORENTA O. Intravenous chemotherapy with synchronization in advanced cancer of oral cavity and oropharynx. Z Krebsforsch 1977; 90: 149-159.
4. BENTZEN SM, JOHANSEN LV, OVERGAARD J, THAMES HD. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1991; 20: 1197-1206.
5. BERGER C, CHAPET S, REYNAUD-BOUGNOUX A, GARAND G, LE FLOCH O et al. Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C. Eur J Cancer 1996; 32: 1707-1711.
6. BLACK RJ, GLUCKMAN IL, SHUMRICK DA. Multiple primary tumours of the upper aerodigestive tract. Clin Otolaryngol 1983; 8: 277-281.
7. BUDACH VG, GEISMAR D, HAAKE K, STUSCHKE M, BAUMANN M et al. Hemoglobin is an independent prognostic factor in locally advanced head & neck cancer - three year results from a German multicentre trial (ARO 95/6). Int J Radiat Oncol Biol Phys 2001; 51 Suppl 1: 183-184.
8. CALAIS G, ALFONSI M, BARDET E, SIRE C, GERMAIN T et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-staged oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-2086.
9. CALAIS G, ALFONSI M, BARDET E, SIRE C, GERMAIN T et al. Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. Final results oft he 94-01 GORTEC randomized study. Int J Radiat Oncol Biol Phys 2001; 51 Suppl 1: 1-2.
10. Common Toxicity Criteria Version 2.0. National Cancer Institute 1999.
11. COOPER JS, PAJAK TF, RUBIN P, TUPCHONG L, BRADY LW et al. Second malignancy in patients who have head and neck cancer: Incidence, effect on survival and implicantions based on RTOG experience. Int J Radiat Oncol Biol Phys 1989; 17: 449-456.
12. COX DR. Regression models and life-tables. J Royal Stat Soc 1972; 34: 187-220.
13. DALY T, PAULSEN MG, DENHAM JW, PETERS LJ, LAMB DS et al. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Radiother Oncol 2003; 68: 113-122.
14. ERKAL HS, MENDENHALL WM, AMDUR RJ, VILLARET DB, STRINGER SP. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol 2001; 19: 1358-1362.
15. ESCHWEGE F, SANCHO-GARNIER H, GERARD JP. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoidal carcinoma of the oropharynx: Experience of the European Organization for Resarch and Treatment of Cancer. Natl Cancer Inst Monogr 1988; 6: 275-278.
16. FOWLER JF. The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1998; 62: 679-694.
17. FU KK, PHILLIPS TL, SILVERBERG IJ, JACOBS C, GEOFFINET DR et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of Northern California Oncology Group randomized trial. J Clin Oncol 1987; 5: 1410-1418.
18. GLASER CM, MILLESI W, KORNEK GV, LANG S, SCHÜLL B et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 2001; 50: 705-715.
19. GRAU C AND OVERGAARD J. Radiosensitizing and cytotoxic properties of mitomycin C in a CH3 mouse mammary carcinoma in vivo. Int J Radiat Oncol Biol Phys 1991; 20: 265-269.
20. GRAU C, PRAKASH JA, JABEEN K, KHAN AR, ABEYAKOON S et al. Radiotherapy with or without mitomycin C in the treatment of locally advanced head and neck cancer: results of the IAEA multicenter randomized trial. Radiother Oncol 2003; 67: 17-26.
21. HADDAD E, MAZERON JJ, MARTIN M, VERGNES L, BRUN B et al. Comparison of concomitant radiotherapy and chemotherapy with radiotherapy alone in cancers of the head and neck: Results of the randomized trial. Bull Cancer Radiother 1996; 83: 97-103.
22. KAPLAN EL, MEIER P. Nonparametric estimation from incomplete observations. JASA 1958; 53: 457-481.
23. KENNEDY KA, ROCKWELL S, SARTORELLI AC. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumour cells. Cancer Res 1980; 40: 2356-2360.
24. MC GEE KP, FEIN DA, LEE WR, HANLON AL, RIDGE JA et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. Int J Radiat Oncol Biol Phys 1995; 32: 161.
25. LEE RW, BERKEY B, MARCIAL V, FU KK, COOPER JS et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998; 42: 1069-1075.
26. MERLANO M, VITALE V, ROSSO R, BENASSO M, CORVO R et al. Treatment of advanced squamous-cell carcinoma of the head and neck. N Engl J Med 1992; 327: 1115-1121.
27. OLMI P, CRISPINO S, FALLAI C, TORRI V, ROSSI F et al. Locoregionally advanced carcinoma of the oropharynx: Conventional radiotherapy vs. Accelerated hyperfractionated radiotherapy vs concomitant radiotherapy and chemotherapy - a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003; 55: 78-92.
28. OVERGAARD J, HANSEN HS, ANDERSEN AP, HJELM-HANSEN M, JORGENSEN K et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 1065-1068.
29. OVERGARD J. Sensititation of hypoxic tumour cells - clinical experience. Int J Radiat Oncol Biol Phys 1989; 56: 801-811.
30. PARKER RD, ENDSTROM JE. Second primary cancers of the head and neck following treatment of initial primary head and neck cancers. Int J Radiat Oncol Biol Phys 1988; 14: 561-564.
31. PEREZ CA, PURDY JA, BREAUX SR, OGURA JH, VON ESSEN S. A nonrandomized comparison of preoperative radiation and surgery or radiation alone: Long-term results. Cancer 1982; 50: 2314-2322.
32. PIGNON JP, BOURHIS J, DOMENGE C, DESIGNE L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three metaanalyses of updated individual data. MACH-NC Collaborative Group. Lancet 2000; 355: 949-955.
33. PROSNITZ RG, YAO B, FARRELL CL, CLOUGH R, BRIZEL DM. Pretreatment hemoglobin levels are correlated with the effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2002; 54 Suppl 1: 73.
34. RUDAT V, DIETZ A, SCHRAMM O, CONRADT C, MAIER H et al. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol 1999; 53: 119-125.
35. SCHWARTZ LH, OZSAHIN M, ZHANG GN, TOUBOUL E, DE VATAIRE F et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994; 74: 1933-1938.
36. SHONS AR, McQUARRIE DG. Multiple primary epidermoid carcinoma of the upper aerodigestive tract. Arch Surg 1985; 120: 1007-1009.
37. SMID L, LESNICAR H, ZAKOTNIK B, SOBA E, BUDIHNA M et al. Radiotherapy, combined with simultaneus chemotherapy with Mitomycin C and Bleomycin for inoperable head and neck cancer - Preliminary report. Int J Radiat Oncol Biol Phys 1995; 32: 769-775.
38. SOBIN LH, WITTEKIND C. TNM classification of malignant tumours. 5th Edition. New York: Wiley, 1997.
39. STAAR S, RUDAT V, STUETZER H, DIETZ A, VOLLING E et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 50: 1161-1171.
40. TEICHER BA, LAZO JS, SARTORELLI AC. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 1981; 41: 73-81.
41. THAMES HD, PETERS LJ, SPANOS W, FLETCHER GH. Dose response of squamous cell carcinomas of the upper respiratory and digestive tracts. Br J Cancer 1980; 41 Suppl IV: 35-38.
42. VERMUND H, KAALHUS O, WINTHER K, TRAUSJO J, THORUD E et al. Bleomycin and radiation therapy for squamous cell carcinoma of the upper aero-digestive tract. Int J Radiat Oncol Biol Phys 1985; 11: 1877-1886.
43. WITHERS HR, PETERS LJ, TAYLOR JM, OWEN JB, MORRISON WH et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of of paterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 1995; 33: 549-562.
44. ZAKOTNIK B, ŠMID L, BUDIHNA M, LESNICAR H, SOBA E et al. Concomitant radiotherapy with mitomycin C and bleomycin compared with radiotherapy alone in inoperable head and neck cancer: final report. Int J Radiat Oncol Biol Phys 1998; 41: 1121-1127.